1. Home
  2. ETON vs NEON Comparison

ETON vs NEON Comparison

Compare ETON & NEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • NEON
  • Stock Information
  • Founded
  • ETON 2017
  • NEON 1997
  • Country
  • ETON United States
  • NEON Sweden
  • Employees
  • ETON N/A
  • NEON N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • NEON Industrial Machinery/Components
  • Sector
  • ETON Health Care
  • NEON Technology
  • Exchange
  • ETON Nasdaq
  • NEON Nasdaq
  • Market Cap
  • ETON 388.3M
  • NEON 428.0M
  • IPO Year
  • ETON 2018
  • NEON 2007
  • Fundamental
  • Price
  • ETON $14.39
  • NEON $21.08
  • Analyst Decision
  • ETON Strong Buy
  • NEON Strong Buy
  • Analyst Count
  • ETON 3
  • NEON 1
  • Target Price
  • ETON $29.67
  • NEON $16.50
  • AVG Volume (30 Days)
  • ETON 420.1K
  • NEON 331.9K
  • Earning Date
  • ETON 08-07-2025
  • NEON 08-11-2025
  • Dividend Yield
  • ETON N/A
  • NEON N/A
  • EPS Growth
  • ETON N/A
  • NEON N/A
  • EPS
  • ETON N/A
  • NEON N/A
  • Revenue
  • ETON $48,327,000.00
  • NEON $2,807,000.00
  • Revenue This Year
  • ETON $101.12
  • NEON N/A
  • Revenue Next Year
  • ETON $45.71
  • NEON $39.01
  • P/E Ratio
  • ETON N/A
  • NEON N/A
  • Revenue Growth
  • ETON 40.88
  • NEON N/A
  • 52 Week Low
  • ETON $3.25
  • NEON $2.22
  • 52 Week High
  • ETON $21.48
  • NEON $29.90
  • Technical
  • Relative Strength Index (RSI)
  • ETON 45.76
  • NEON 46.12
  • Support Level
  • ETON $13.78
  • NEON $20.02
  • Resistance Level
  • ETON $15.73
  • NEON $29.90
  • Average True Range (ATR)
  • ETON 0.75
  • NEON 2.23
  • MACD
  • ETON -0.01
  • NEON -1.16
  • Stochastic Oscillator
  • ETON 31.98
  • NEON 23.48

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

Share on Social Networks: